Cite
HARVARD Citation
Lalezari, J. et al. (2015). Safety and efficacy of the HIV-1 attachment inhibitor prodrug BMS-663068 in treatment-experienced individuals: 24 week results of AI438011, a phase 2b, randomised controlled trial. Lancet. 2 (10), pp. e427-e437. [Online].